|Bid||0.710 x 3100|
|Ask||0.720 x 3000|
|Day's Range||0.650 - 0.738|
|52 Week Range||0.390 - 8.810|
|PE Ratio (TTM)||-0.25|
|Earnings Date||Oct 30, 2017 - Nov 3, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.88|
Q2 2017 Tandem Diabetes Care Inc Earnings Call
Tandem Diabetes Care®, Inc. , a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced enrollment of the first patients in an at-home pivotal trial for its t:slim X2™ Insulin Pump using Tandem’s predictive low glucose suspend technology.
NEW YORK, NY / ACCESSWIRE / August 15, 2017 / U.S. markets rebounded sharply Monday as geopolitical tensions eased after Secretary of State Rex Tillerson and U.S. Secretary of Defense James Mattis commented ...